Diabetes Medications

Microdosing is the off-label use of GLP-1 medications at lower than approved doses for diabetes or weight management. There are numerous reasons people may consider microdosing, including cost savings and minimizing side effects.

Tzield has been shown to delay the onset of type 1 diabetes by an average of two years. Here’s more about screening and whether treatment may be right for you.

Survodutide is a new investigational dual GLP-1 injectable medication being tested for weight management in clinical trials.

Results from recent clinical trials suggest that retatrutide, a first-of-its-kind experimental drug, causes unprecedented levels of weight loss. Its effects on blood sugar for diabetes are comparable to currently available GLP-1 drugs like Ozempic. 

Off-label use of medications like Ozempic, Wegovy, Mounjaro, and Zepbound is becoming increasingly common to address weight management, insulin resistance, and diabetes related complications in type 1 diabetes. New expert recommendations provide a framework for safe use while large trials are ongoing. 

Afrezza, an ultra rapid-acting inhaled insulin, offers an alternative to injections for mealtime glucose management. It starts working in 12 minutes and works well for some, but not for all people with diabetes.